NextGen
Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality
Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare
information systems and connectivity solutions, announced today it has
entered into an agreement with Nipro Diagnostics, Inc. to integrate its
TRUEresult blood glucose monitoring system into the NextGen®
Ambulatory EHR.
This partnership provides NextGen Ambulatory EHR users instant access to
data points captured by patients at home who are using the Nipro
TRUEresult blood glucose monitoring system. Physicians will gain an
immediate benefit from seamlessly performing diagnostic tests with
direct entry of information into a patient's chart. This eliminates the
need to manually re-enter patient data while streamlining processes,
reducing data entry errors and increasing efficiencies.
The Nipro Diagnostic Blood Glucose interface imports blood glucose
readings from the TRUEresult device into NextGen Healthcare's Ambulatory
EHR, allowing users to view and graph the information captured. The
NextGen® Nipro Glucose Meter Interface enables electronic
downloading of glucose measurements from a Nipro Diagnostics blood
glucose meter into the EHR, automatically populating the appropriate
templates and fields, where data can be viewed and analyzed by a
physician.